161 related articles for article (PubMed ID: 21196413)
21. Effects of meloxicam or tolfenamic acid administration on the pain and stress responses of Merino lambs to mulesing.
Paull DR; Lee C; Atkinson SJ; Fisher AD
Aust Vet J; 2008 Aug; 86(8):303-11. PubMed ID: 18673471
[TBL] [Abstract][Full Text] [Related]
22. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.
Kankaanranta H; Moilanen E; Vapaatalo H
Inflammation; 1991 Apr; 15(2):137-43. PubMed ID: 1649132
[TBL] [Abstract][Full Text] [Related]
23. The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression.
Liu X; Abdelrahim M; Abudayyeh A; Lei P; Safe S
Mol Cancer Ther; 2009 May; 8(5):1207-17. PubMed ID: 19435870
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of tolfenamic acid.
Corell T
Pharmacol Toxicol; 1994; 75 Suppl 2():14-21. PubMed ID: 7816775
[No Abstract] [Full Text] [Related]
25. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
[TBL] [Abstract][Full Text] [Related]
26. Comparative studies with tolfenamic acid in rheumatic disorders.
Ardia A; Franchini S; Baggio A; Cornelli U
Pharmacol Toxicol; 1994; 75 Suppl 2():66-71. PubMed ID: 7816787
[No Abstract] [Full Text] [Related]
27. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
Harris RE; Beebe-Donk J; Doss H; Burr Doss D
Oncol Rep; 2005 Apr; 13(4):559-83. PubMed ID: 15756426
[TBL] [Abstract][Full Text] [Related]
28. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
Kankaanranta H; Moilanen E; Vapaatalo H
Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
[TBL] [Abstract][Full Text] [Related]
29. Tolfenamic acid: clinical experience in rheumatic diseases.
Isomäki H
Pharmacol Toxicol; 1994; 75 Suppl 2():64-5. PubMed ID: 7816786
[TBL] [Abstract][Full Text] [Related]
30. Comparison of post-operative analgesic efficacy of tolfenamic acid and robenacoxib in ovariohysterectomized cats.
Sattasathuchana P; Phuwapattanachart P; Thengchaisri N
J Vet Med Sci; 2018 Jun; 80(6):989-996. PubMed ID: 29695672
[TBL] [Abstract][Full Text] [Related]
31. The involvement of lipid raft pathway in suppression of TGFβ-mediated metastasis by tolfenamic acid in hepatocellular carcinoma cells.
Sun J; Tao R; Mao T; Feng Z; Guo Q; Zhang X
Toxicol Appl Pharmacol; 2019 Oct; 380():114696. PubMed ID: 31381904
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug.
Krymchantowski AV; Barbosa JS
Arq Neuropsiquiatr; 2001 Sep; 59(3-B):708-11. PubMed ID: 11593269
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of the influence of tolfenamic acid (Clotam) and diclofenac sodium (Voltaren) on the gastrointestinal mucosa in patients with a history of NSAID-related dyspeptic symptoms.
Hendel L; Larsen E; Bonnevie O
Pharmacol Toxicol; 1994; 75 Suppl 2():49-50. PubMed ID: 7816781
[No Abstract] [Full Text] [Related]
34. The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid.
Zhang X; Lee SH; Min KW; McEntee MF; Jeong JB; Li Q; Baek SJ
Cancer Prev Res (Phila); 2013 Dec; 6(12):1337-47. PubMed ID: 24104354
[TBL] [Abstract][Full Text] [Related]
35. Effects of flunixin, tolfenamic acid, R(-) and S(+) ketoprofen on the response of equine synoviocytes to lipopolysaccharide stimulation.
Landoni MF; Foot R; Frean S; Lees P
Equine Vet J; 1996 Nov; 28(6):468-75. PubMed ID: 9049496
[TBL] [Abstract][Full Text] [Related]
36. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.
Kankaanranta H; Moilanen E; Vapaatalo H
Inflammation; 1993 Aug; 17(4):417-25. PubMed ID: 8406686
[TBL] [Abstract][Full Text] [Related]
37. Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality.
Dunlap T; Abdul-Hay SO; Chandrasena RE; Hagos GK; Sinha V; Wang Z; Wang H; Thatcher GR
Nitric Oxide; 2008 Sep; 19(2):115-24. PubMed ID: 18485921
[TBL] [Abstract][Full Text] [Related]
38. Prolonged treatment with tolfenamic acid in inflammatory rheumatic diseases.
Kajander A; Martio J; Mutru O; Gothoni G
Scand J Rheumatol; 1976; 5(3):158-60. PubMed ID: 1086507
[TBL] [Abstract][Full Text] [Related]
39. Reduction of amyloid-β deposition and attenuation of memory deficits by tolfenamic acid.
Subaiea GM; Ahmed AH; Adwan LI; Zawia NH
J Alzheimers Dis; 2015; 43(2):425-33. PubMed ID: 25096618
[TBL] [Abstract][Full Text] [Related]
40. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality.
Rüegg C; Zaric J; Stupp R
Ann Med; 2003; 35(7):476-87. PubMed ID: 14649330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
